Beli, a company known for its fertility and prenatal supplements, has launched at-home fertility testing kits for both men and women. This new offering aims to provide users with data-driven insights into their reproductive health, complementing Beli’s existing line of supplements.
The company has partnered with IHDLab to develop these testing kits. For men, the test measures four key fertility hormones: Testosterone, Total Testosterone, Luteinizing Hormone (LH), and Follicle-Stimulating Hormone (FSH). The women’s test focuses on Anti-Müllerian Hormone (AMH), a marker of ovarian reserve.
Joni Hanson Davis, CEO of Beli, stated, “As a company deeply invested in the fertility journey, we noticed a major missing link in the process—the time before someone is even thinking about pregnancy to when they need to seek fertility care. This period is often overlooked, yet it’s so important for laying the foundation for a healthy pregnancy.”
Beli’s move into at-home testing builds on its established presence in the fertility supplement market. The company was one of the first to introduce a supplement specifically designed for men’s fertility. Its product line includes supplements for both men and women, covering various stages from preconception to pregnancy and breastfeeding.
The new testing kits are designed to work in conjunction with Beli’s supplements. This integrated approach aims to allow users to tailor their supplement regimen based on their test results, providing a more personalized approach to fertility health.
Jim Chen MD MPH, Chief of Business Development at IHDLab, commented on the partnership: “Partnering with Beli allows us to deliver accessible, advanced fertility insights. By combining our testing capabilities with Beli’s supplements, we’re empowering individuals to make informed decisions about their reproductive health.”
